Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 19;45(1):21.
doi: 10.1186/1297-9716-45-21.

Strategies and hurdles using DNA vaccines to fish

Linn B Hølvold, Anne I Myhr, Roy A Dalmo  1
Affiliations
Review

Strategies and hurdles using DNA vaccines to fish

Linn B Hølvold et al. Vet Res. .

Abstract

DNA vaccinations against fish viral diseases as IHNV at commercial level in Canada against VHSV at experimental level are both success stories. DNA vaccination strategies against many other viral diseases have, however, not yet yielded sufficient results in terms of protection. There is an obvious need to combat many other viral diseases within aquaculture where inactivated vaccines fail. There are many explanations to why DNA vaccine strategies against other viral diseases fail to induce protective immune responses in fish. These obstacles include: 1) too low immunogenicity of the transgene, 2) too low expression of the transgene that is supposed to induce protection, 3) suboptimal immune responses, and 4) too high degradation rate of the delivered plasmid DNA. There are also uncertainties with regard distribution and degradation of DNA vaccines that may have implications for safety and regulatory requirements that need to be clarified. By combining plasmid DNA with different kind of adjuvants one can increase the immunogenicity of the transgene antigen - and perhaps increase the vaccine efficacy. By using molecular adjuvants with or without in combination with targeting assemblies one may expect different responses compared with naked DNA. This includes targeting of DNA vaccines to antigen presenting cells as a central factor in improving their potencies and efficacies by means of encapsulating the DNA vaccine in certain carriers systems that may increase transgene and MHC expression. This review will focus on DNA vaccine delivery, by the use of biodegradable PLGA particles as vehicles for plasmid DNA mainly in fish.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Evensen Ø, Leong JA. DNA vaccines against viral diseases of farmed fish. Fish Shellfish Immun. 2013;35:1751–1758. doi: 10.1016/j.fsi.2013.10.021. - DOI - PubMed
    1. Wang G, Pan L, Zhang Y. Approaches to improved targeting of DNA vaccines. Hum Vaccin. 2011;7:1271–1281. doi: 10.4161/hv.7.12.17983. - DOI - PubMed
    1. Board TNBA. Regulation of DNA vaccines and gene therapy on animals. 2003. [ http://www.bion.no/filarkiv/2010/07/2006_03_regulation_of_DNA_vaccines.pdf]
    1. Ballesteros NA, Saint-Jean SS, Perez-Prieto SI, Coll JM. Trout oral VP2 DNA vaccination mimics transcriptional responses occurring after infection with infectious pancreatic necrosis virus (IPNV) Fish Shellfish Immunol. 2012;33:1249–1257. doi: 10.1016/j.fsi.2012.09.004. - DOI - PubMed
    1. Heppell J, Lorenzen N, Armstrong NK, Wu T, Lorenzen E, Einer-Jensen K, Schorr J, Davis HL. Development of DNA vaccines for fish: vector design, intramuscular injection and antigen expression using viral haemorrhagic septicaemia virus genes as model. Fish Shellfish Immunol. 1998;8:271–286. doi: 10.1006/fsim.1997.0133. - DOI

MeSH terms